{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:09:25Z","timestamp":1761491365376,"version":"3.43.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:p>6-mercaptopurine is a mainstay of acute lymphoblastic leukemia treatment. It has a narrow therapeutic window, dictated by its metabolite, thioguanine and 6-methylmercaptopurine. Skin manifestations usually consist of mild facial rash or hypersensitivity exanthems. We report a child who developed a painful acral rash and mucositis while undergoing maintenance therapy for B-cell acute lymphoblastic leukemia without infectious or known drug etiology. Thiopurine metabolites were skewed toward 6-methylmercaptopurine. Two weeks after allopurinol was added and 6-mercaptopurine (6-MP) dose adjusted, the cutaneous manifestations and other constitutional symptoms resolved. We posit that the rash was because of 6-MP toxicity related to skewed metabolism, adding to the growing list of toxicity related to altered 6-MP metabolism.<\/jats:p>","DOI":"10.1097\/mph.0000000000002434","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T19:01:07Z","timestamp":1645210867000},"page":"398-401","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Acral Skin Rash Caused by Altered Mercaptopurine Metabolism in Maintenance Therapy for B-Cell Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"44","author":[{"given":"Jennifer","family":"Newcome","sequence":"first","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen B.","family":"Geib","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Thompson","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Gold","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"},{"name":"Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"176","DOI":"10.12688\/f1000research.17760.2","article-title":"Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia","volume":"8","author":"Zhang","year":"2019","journal-title":"F1000Res"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10620-021-06836-3","article-title":"Adverse events of thiopurine therapy in pediatric inflammatory bowel disease and correlations with metabolites: a cohort study","volume":"67","author":"Jagt","year":"2021","journal-title":"Dig Dis Sci"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3389\/fonc.2020.01129","article-title":"Use of allopurinol to mitigate 6-mercaptopurine associated gastrointestinal toxicity in acute lymphoblastic leukemia","volume":"10","author":"Conneely","year":"2020","journal-title":"Front Oncol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MPH.0000000000002117","article-title":"Allopurinol to prevent mercaptopurine adverse effects in children and young adults with acute lymphoblastic leukemia","volume":"43","author":"Kamojjala","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"e28360","DOI":"10.1002\/pbc.28360","article-title":"Allopurinol use during pediatric acute lymphoblastic leukemia maintenance therapy safely corrects skewed 6-mercaptopurine metabolism, improving inadequate myelosuppression and reducing gastrointestinal toxicity","volume":"67","author":"Cohen","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/pbc.24913","article-title":"Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism","volume":"61","author":"Brackett","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/1756283X17733657","article-title":"Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD","volume":"10","author":"Moreau","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1080\/10428194.2019.1702183","article-title":"Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL)","volume":"61","author":"Stuckert","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/pbc.25841","article-title":"Maintenance treatment with low-dose mercaptopurine in combination with allopurinol in children with acute lymphoblastic leukemia and mercaptopurine-induced pancreatitis","volume":"63","author":"Zerra","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"e1003","DOI":"10.1097\/MPH.0000000000001939","article-title":"A retrospective review of mercaptopurine metabolism reveals high rate of patients with suboptimal metabolites successfully corrected with allopurinol","volume":"43","author":"Vasta","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MPH.0000000000000499","article-title":"Allopurinol use during maintenance therapy for acute lymphoblastic leukemia avoids mercaptopurine-related hepatotoxicity","volume":"38","author":"Giamanco","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bcp.2013.06.002","article-title":"Mechanism of allopurinol induced TPMT inhibition","volume":"86","author":"Blaker","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/apt.12491","article-title":"Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease","volume":"38","author":"Moran","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/08916934.2013.873414","article-title":"Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy","volume":"47","author":"Marzano","year":"2014","journal-title":"Autoimmunity"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jaip.2018.10.018","article-title":"Azathioprine hypersensitivity syndrome in a cohort of antineutrophil cytoplasmic antibody-associated vasculitis patients","volume":"7","author":"Hessels","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/apt.14571","article-title":"Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine\/mercaptopurine nonresponders (AAA Study)","volume":"47","author":"Friedman","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.crohns.2010.02.009","article-title":"Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD","volume":"4","author":"Govani","year":"2010","journal-title":"J Crohns Colitis"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2125.2010.03867.x","article-title":"Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy","volume":"71","author":"Adam de Beaumais","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1080\/15257770.2014.904519","article-title":"Assessment of mercaptopurine (6MP) metabolites and 6MP metabolic key-enzymes in childhood acute lymphoblastic leukemia","volume":"33","author":"Wojtuszkiewicz","year":"2014","journal-title":"Nucleosides Nucleotides Nucleic Acids"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:03:59Z","timestamp":1754337839000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002434","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2022,2,18]]},"assertion":[{"value":"2021-09-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}